Skip to main content
. 2008 Sep 11;3(9):e3193. doi: 10.1371/journal.pone.0003193

Figure 5. Effect of initial efficacy on effectiveness of PEV for different transmission settings delivered via EPI (a–c), EPI with boosters (d–f) and EPI with 70% mass vaccination (g–i).

Figure 5

Results obtained assuming a vaccine half-life of 10 years and homogeneity value of 10.